Difficulty: Medium
Average Score: 80%
Practice
Which of the following muscular relaxants causes hypotension and bronchospasm?
Correct answer
C
Rationale
In pharmacology across the lifespan, understanding the effects of muscle relaxants is crucial for safe patient care. In this question, the correct answer is C) Tubocurarine.
Tubocurarine is a non-depolarizing neuromuscular blocking agent that can cause hypotension and bronchospasm as adverse effects. It competes with acetylcholine at the motor end plate, leading to muscle paralysis. The hypotension results from histamine release and blockade of autonomic ganglia, while bronchospasm can occur due to histamine release and vagal stimulation.
A) Vecuronium is a non-depolarizing muscle relaxant but is less likely to cause hypotension and bronchospasm compared to Tubocurarine.
B) Succinylcholine is a depolarizing muscle relaxant that can cause fasciculations, hyperkalemia, and malignant hyperthermia but not hypotension and bronchospasm.
D) Rapacuronium is associated with bronchospasm and was withdrawn from the market due to safety concerns, but it is not specifically known for causing hypotension.
Educationally, this question highlights the importance of knowing the side effect profiles of different muscle relaxants to anticipate and manage potential complications during anesthesia and critical care scenarios, emphasizing patient safety and individualized treatment plans.
Tubocurarine is a non-depolarizing neuromuscular blocking agent that can cause hypotension and bronchospasm as adverse effects. It competes with acetylcholine at the motor end plate, leading to muscle paralysis. The hypotension results from histamine release and blockade of autonomic ganglia, while bronchospasm can occur due to histamine release and vagal stimulation.
A) Vecuronium is a non-depolarizing muscle relaxant but is less likely to cause hypotension and bronchospasm compared to Tubocurarine.
B) Succinylcholine is a depolarizing muscle relaxant that can cause fasciculations, hyperkalemia, and malignant hyperthermia but not hypotension and bronchospasm.
D) Rapacuronium is associated with bronchospasm and was withdrawn from the market due to safety concerns, but it is not specifically known for causing hypotension.
Educationally, this question highlights the importance of knowing the side effect profiles of different muscle relaxants to anticipate and manage potential complications during anesthesia and critical care scenarios, emphasizing patient safety and individualized treatment plans.